Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 17.22% is 38% below its 5-year average of 27.99%, around the middle of its 5-year range (2.78%–46.29%).
9.22% above its 12-month average of 15.77%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 25.34%.
GROSS MARGIN
17.22%
GROSS MARGIN AVG TTM
15.77%
GROSS MARGIN AVG 3Y
22.71%
GROSS MARGIN AVG 5Y
27.99%
GROSS MARGIN AVG 10Y
30.31%
GROSS MARGIN AVG 15Y
27.74%
GROSS MARGIN AVG 20Y
29.21%
CURRENT VS TTM AVG
+9.22%
CURRENT VS 3Y AVG
-24.17%
CURRENT VS 5Y AVG
-38.47%
CURRENT VS 10Y AVG
-43.19%
CURRENT VS 15Y AVG
-37.92%
CURRENT VS 20Y AVG
-41.04%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-58.39%
vs the sector median at left
Precision Optics Corporation, Inc.
Market Cap
$49.25M
Gross Margin
17.22%
TTM Avg
15.77%
3Y Avg
22.71%
5Y Avg
27.99%
Market Cap
$49.45M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$48.51M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$50.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$50.00M
Gross Margin
N/A
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | $49.25M | 17.22% | 15.77% | 22.71% | 27.99% |
| INmune Bio, Inc. (INMB)vs › | $49.45M | 100.00% | 100.00% | 100.00% | 100.00% |
| Apollomics, Inc. (APLM)vs › | $48.80M | 97.00% | 98.50% | 99.25% | 99.50% |
| TELA Bio, Inc. (TELA)vs › | $48.99M | 67.81% | 67.38% | 67.17% | 65.70% |
| biote Corp. (BTMD)vs › | $50.72M | 71.46% | 70.99% | 69.42% | 67.35% |
| Clene Inc. (CLNN)vs › | $49.96M | 78.50% | 79.02% | 83.51% | 77.08% |
| Microbot Medical Inc. (MBOT)vs › | $48.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A | 50.00% | 25.00% | 16.67% |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
17.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 25.34% |
| 2026-03-31 | 23.61% |
| 2025-12-31 | 2.78% |
| 2025-09-30 | 14.17% |
| 2025-06-30 | 12.93% |
| 2025-03-31 | 9.99% |
| 2024-12-31 | 23.64% |
| 2024-09-30 | 26.62% |
| 2024-06-30 | 21.72% |
| 2024-03-31 | 35.45% |
| 2023-12-31 | 30.08% |
| 2023-09-30 | 33.87% |
| 2023-06-30 | 35.01% |
| 2023-03-31 | 34.39% |
| 2022-12-31 | 46.29% |
| 2022-09-30 | 33.91% |
| 2022-06-30 | 30.07% |
| 2022-03-31 | 37.15% |
| 2021-12-31 | 28.73% |
| 2021-09-30 | 27.35% |
| 2021-06-30 | 29.40% |
| 2021-03-31 | 33.28% |
| 2020-12-31 | 30.68% |
| 2020-09-30 | 35.36% |
| 2020-06-30 | 29.21% |
| 2020-03-31 | 34.41% |
| 2019-12-31 | 32.82% |
| 2019-09-30 | 38.73% |
| 2019-06-30 | 35.64% |
| 2019-03-31 | 32.89% |
| 2018-12-31 | 24.07% |
| 2018-09-30 | 29.66% |
| 2018-06-30 | 38.25% |
| 2018-03-31 | 32.10% |
| 2017-12-31 | 36.94% |
| 2017-09-30 | 37.59% |
| 2017-06-30 | 25.01% |
| 2017-03-31 | 28.29% |
| 2016-12-31 | 24.67% |
| 2016-09-30 | 19.66% |
| 2016-06-30 | 33.15% |
| 2016-03-31 | 23.98% |
| 2015-12-31 | 22.73% |
| 2015-09-30 | 15.42% |
| 2015-06-30 | 21.88% |
| 2015-03-31 | 27.40% |
| 2014-12-31 | 16.64% |
| 2014-09-30 | 13.50% |
| 2014-06-30 | 16.17% |
| 2014-03-31 | 22.70% |
| 2013-12-31 | 20.38% |
| 2013-09-30 | 28.68% |
| 2013-06-30 | 35.63% |
| 2013-03-31 | 24.23% |
| 2012-12-31 | 16.11% |
| 2012-09-30 | 22.98% |
| 2012-06-30 | 38.42% |
| 2012-03-31 | 2.70% |
| 2011-12-31 | 22.54% |
| 2011-09-30 | 27.60% |
| 2011-06-30 | 27.41% |
| 2011-03-31 | 27.13% |
| 2010-12-31 | 21.29% |
| 2010-09-30 | 51.50% |
| 2010-06-30 | 50.62% |
| 2010-03-31 | 43.09% |
| 2009-12-31 | 34.80% |
| 2009-09-30 | 35.14% |
| 2009-06-30 | 46.71% |
| 2009-03-31 | 36.68% |
| 2008-12-31 | 51.03% |
| 2008-09-30 | 46.10% |
| 2008-06-30 | 40.00% |
| 2008-03-31 | 25.59% |
| 2007-12-31 | 15.53% |
| 2007-09-30 | 27.80% |
| 2007-06-30 | 20.63% |
| 2007-03-31 | 91.01% |
| 2006-12-31 | 32.79% |
| 2006-09-30 | -2.40% |
| 2006-06-30 | 5.98% |
| 2006-03-31 | 3.71% |
| 2005-12-31 | 7.95% |
| 2005-09-30 | -24.29% |
| 2005-06-30 | -93.09% |
| 2005-03-31 | -13.17% |
| 2004-12-31 | -44.13% |
| 2004-09-30 | -34.95% |
| 2004-06-30 | -91.87% |
| 2004-03-31 | -48.93% |
| 2003-12-31 | -103.42% |
| 2003-09-30 | 8.23% |
| 2003-06-30 | -27.78% |
| 2003-03-31 | 34.09% |
| 2002-12-31 | 18.58% |
| 2002-09-30 | 1.97% |
